Gold ₹15,465.27/g ▲ +0.00% Silver ₹236.54/g ▲ +0.00% Platinum ₹5,373.41/g ▲ +0.00% Palladium ₹4,043.13/g ▲ +0.00% Rhodium ₹24,633.32/g ▲ +0.00% Copper ₹1,267.24/kg ▲ +0.00% Aluminium ₹282.47/kg ▲ +0.00% Cobalt ₹4,900.93/kg ▲ +0.00% Gallium ₹23,434.80/kg ▲ +0.00% Indium ₹71,014.54/kg ▲ +0.00% Iron Ore ₹8.29/kg ▲ +0.00% Lead ₹165.04/kg ▲ +0.00% Lithium ₹1,956.13/kg ▲ +0.00% Molybdenum ₹7,973.00/kg ▲ +0.00% Nickel ₹1,460.35/kg ▲ +0.10% Neodymium ₹12,330.69/kg ▲ +0.00% Tin ₹4,862.97/kg ▲ +0.00% Tellurium ₹10,393.95/kg ▲ +0.00% Uranium ₹16,622.65/kg ▲ +0.00% Zinc ₹327.11/kg ▲ +0.00% Crude Oil (Brent) ₹8,456.42/bbl ▲ +0.00% Crude Oil (WTI) ₹7,870.56/bbl ▲ +0.01% Gasoline ₹303.61/gal ▲ +0.00% Natural Gas ₹259.87/MMBtu ▲ +0.00%
Lithium

Albemarle's Pivot to a Lithium-and-Bromine Pure Play Pays Off With a Record Quarter

Bullish · 78% confidence · August 15, 2026
Albemarle's Pivot to a Lithium-and-Bromine Pure Play Pays Off With a Record Quarter
Breaking: Albemarle Corporation reported second-quarter 2026 results on August 6, 2026, showing net sales of $1.74 billion, up 31% year-over-year, and adjusted EBITDA of $858 million, more than double the prior year's figure, as its Energy Storage lithium segment posted a 57% EBITDA margin on realized pricing near $20 a kilogram of lithium carbonate equivalent. Adjusted earnings per share came in at $3.75 against a Wall Street consensus of $3.03, and the stock rose 11.5% on the results. The quarter capped a portfolio shift Albemarle had been building toward since October 2025, when it agreed to sell a 51% controlling stake in its Ketjen refining-catalyst business to KPS Capital Partners — a transaction that closed on March 2, 2026 and, combined with an earlier sale of its Eurecat joint-venture stake, brought in roughly $670 million of pre-tax proceeds and left the company focused on lithium and bromine.

Key Takeaways 85% confidence

  • Albemarle's Q2 2026 net sales rose 31% year-over-year to $1.74 billion, with adjusted EBITDA more than doubling to $858 million and a 49% margin, up from 25% a year earlier.
  • The Energy Storage (lithium) segment drove the improvement: net sales rose 78% to $1.277 billion and EBITDA jumped 229% to $724 million, a 57% margin, on 65,000 tonnes of lithium carbonate equivalent sold at roughly $20/kg average realized pricing.
  • Albemarle completed the sale of a 51% controlling stake in its Ketjen catalyst business to KPS Capital Partners on March 2, 2026, and combined with an earlier Eurecat stake sale, the two deals brought in about $670 million of pre-tax proceeds.
  • The company raised full-year 2026 guidance to $5.7-$6.0 billion in net sales and $2.4-$2.6 billion in adjusted EBITDA, while trimming planned capital expenditure to roughly $500 million.
  • Specialties (bromine) guidance was also raised, to $1.4-$1.6 billion in net sales and $275-$325 million in adjusted EBITDA, after the segment posted 20% sales growth and 61% EBITDA growth in the quarter.

Albemarle's Q2 2026 net sales rose 31% to $1.74 billion and adjusted EBITDA more than doubled to $858 million, as its completed Ketjen divestiture and a trimmed capex plan sharpened its focus on lithium and bromine.

Analysis 82% confidence

Albemarle Corporation's second-quarter 2026 results, reported August 6, 2026, read like confirmation that a strategy the company had been signaling for nearly a year is now showing up in the numbers. Net sales climbed 31% year-over-year to $1.74 billion, and adjusted EBITDA more than doubled to $858 million, lifting the company's overall margin to 49% from 25% a year earlier. Adjusted earnings per share came in at $3.75, well ahead of the $3.03 Wall Street had penciled in, and the stock climbed 11.5% on the day.

Almost all of that improvement traces back to one segment. Energy Storage, Albemarle's lithium business, posted net sales of $1.277 billion, up 78% year-over-year, and adjusted EBITDA of $724 million, up 229%, for a 57% margin against 22% a year earlier. The company sold 65,000 tonnes of lithium carbonate equivalent at an average realized price near $20 a kilogram, up 73% from a year ago — a sharp turnaround from the oversupply-driven price collapse that hit lithium producers through 2024 and 2025. Specialties, Albemarle's bromine business, grew more modestly but just as cleanly: net sales rose 20% to $424 million and EBITDA climbed 61% to $118 million, a 28% margin versus 21% a year earlier.

The quarter also closed the loop on a portfolio move that had been underway since October 2025, when Albemarle agreed to sell a 51% controlling stake in Ketjen, its refining-catalyst business, to KPS Capital Partners. That transaction completed March 2, 2026, and combined with an earlier sale of Albemarle's 50% stake in the Eurecat joint venture to Axens SA, the two deals delivered roughly $670 million of combined pre-tax proceeds. The practical effect is that Albemarle now runs as essentially two businesses — lithium and bromine — rather than the broader specialty-chemicals group with a refining-catalyst arm it operated as before. Management used part of the resulting flexibility to trim planned 2026 capital spending to roughly $500 million, down from earlier expectations, while raising full-year guidance to $5.7-$6.0 billion in net sales and $2.4-$2.6 billion in adjusted EBITDA. Specialties guidance moved up too, to $1.4-$1.6 billion in sales and $275-$325 million in EBITDA.

Not everything in the quarter was clean upside. A June 9 fire at the Talison Greenbushes joint venture's CGP3 processing circuit in Western Australia knocked out lithium spodumene concentrate output; the unit restarted August 1 and is expected to reach full run-rate only by the first quarter of 2027. That is a direct reason Albemarle's full-year Energy Storage volume guidance sits at 225,000 to 235,000 tonnes of lithium carbonate equivalent, flat to down 4% from 2025, even as pricing and margins have improved sharply. Chief executive Kent Masters framed the broader market backdrop bluntly on the earnings call: with global lithium carbonate inventories sitting at under three weeks of consumption, he said the industry needs roughly 45% annual supply growth just to keep pace with demand — a rate he called difficult to reach. For a company that spent two years cutting costs and idling capacity through the last downturn, tight supply and a leaner cost base arriving at the same time is the combination that turned a single quarter's results into what looks like the clearest evidence yet that the pivot to lithium is working.

Why This Matters 70% confidence

Albemarle doesn't sell directly into India's retail metal market the way a bullion refiner does, but its results are a useful proxy for the raw-material costs battery manufacturers everywhere are working with, including India's fast-growing lithium-ion cell and pack industry, which imports the overwhelming majority of its lithium chemicals. A leaner, lithium-focused Albemarle posting a $20-a-kilogram realized price and citing sub-three-week global inventories is a signal that the lithium price collapse of 2024-2025, which briefly made battery-grade material unusually cheap, is not returning in the near term. That has direct implications for the cost side of India's electric-vehicle and grid-storage buildout, both of which depend on imported lithium carbonate and hydroxide priced off benchmarks that move with exactly the kind of supply-demand tightness Albemarle's own CEO described on this earnings call.

Price Impact

Albemarle beat consensus earnings estimates, more than doubled adjusted EBITDA, raised full-year guidance and cut planned capex, all while completing a portfolio shift toward higher-margin lithium and bromine businesses — a combination of an earnings beat, guidance raise and structural simplification that typically supports a bullish read, tempered by the CGP3 fire's continued drag on 2026 lithium volumes.

Market Snapshot Computed live

Current Price₹1,956.13/kg
Day Change+0.00%
Week Change+6.59%
Month Change-0.74%
Year Change+114.83%
52-Week High₹2,571.77
52-Week Low₹817.54
All-Time High₹2,571.77
All-Time Low₹653.83

Based on metalscost.com's own tracked India reference price as of 2026-08-16 (current). Volume and open interest aren't tracked by this site and are intentionally left blank rather than estimated.

Technical Analysis Computed live

TrendDowntrend
Trend StrengthModerate
RSI (14)75.9
MACD0.00 / -0.02
MomentumStrong bullish
VolatilityModerate (23.4% ann.)
Support₹1,795.74
Resistance₹1,971.12

Price is mixed relative to its 20-period and 50-period moving averages, showing no clear trend alignment.

Breakout probability: Elevated — price is testing the top of its recent range.

Fundamental Analysis

Supply Drivers 76% confidence

Global lithium carbonate inventories stood at under three weeks of consumption in mid-2026, a level CEO Kent Masters said would require roughly 45% annual supply growth just to keep pace with demand — a bar he called difficult to clear, underscoring how tight raw-material supply has become even as new capacity is added industry-wide.

Mining Production 80% confidence

Albemarle's Talison Greenbushes joint venture in Western Australia lost output to a fire at its CGP3 processing circuit on June 9, 2026; the unit restarted August 1 and is expected to reach full run-rate by the first quarter of 2027, a factor behind Albemarle's 2026 Energy Storage volume guidance of 225,000-235,000 tonnes of lithium carbonate equivalent, flat to down 4% from 2025.

Country Impact 74% confidence

CountryImpactReason
United StatesHighAlbemarle is a US-headquartered, NYSE-listed company, and its capital-allocation decisions — the Ketjen and Eurecat divestitures, a trimmed roughly $500 million 2026 capex plan, and raised guidance — flow directly through US corporate earnings and its Specialties (bromine) manufacturing base. — Albemarle raised its full-year 2026 net sales guidance to $5.7-$6.0 billion and its Specialties segment guidance to $1.4-$1.6 billion after Q2 2026 results reported August 6, 2026.
AustraliaHighAlbemarle's Talison Greenbushes joint venture, its lithium spodumene source in Western Australia, lost production to a fire in June 2026 that is still constraining the company's 2026 volume guidance. — The CGP3 processing circuit at Talison Greenbushes restarted August 1, 2026 after the June 9 fire, with full run-rate not expected until the first quarter of 2027.

Industry Impact 74% confidence

IndustryEffectReason
Energy StoragePositiveAlbemarle's lithium segment posted a 57% EBITDA margin in Q2 2026 on tight global inventories and $20/kg realized pricing, a direct input-cost signal for battery and storage manufacturers.
ChemicalsPositiveAlbemarle's Specialties (bromine) segment grew sales 20% and EBITDA 61% in the quarter, and management raised its full-year guidance for the segment alongside the completed Ketjen catalyst-business divestiture.
MiningNeutralA fire at the Talison Greenbushes joint venture curbed lithium spodumene output for part of the quarter, though the unit has since restarted and is on a path back to full run-rate by early 2027.

Timeline

2025-10-27: Albemarle agrees to sell a 51% controlling stake in its Ketjen refining-catalyst business to KPS Capital Partners.
2026-03-02: Albemarle completes the sale of its 51% Ketjen stake to KPS Capital Partners, bringing combined pre-tax proceeds from the Ketjen and Eurecat sales to about $670 million.
2026-06-09: A fire hits the CGP3 processing circuit at the Talison Greenbushes joint venture in Western Australia, Albemarle's lithium spodumene source.
2026-08-01: The CGP3 circuit restarts after the June fire, with full run-rate targeted for the first quarter of 2027.
2026-08-06: Albemarle reports Q2 2026 results: net sales of $1.74 billion, adjusted EBITDA of $858 million, and raised full-year guidance.

Market Sentiment

Bullish Factors 80% confidence

  • Q2 2026 adjusted EBITDA more than doubled year-over-year to $858 million on a 49% margin, with adjusted EPS of $3.75 beating consensus estimates of $3.03.
  • Full-year 2026 guidance was raised to $5.7-$6.0 billion in net sales and $2.4-$2.6 billion in adjusted EBITDA, alongside a cut in planned capital expenditure to roughly $500 million.
  • The completed Ketjen and Eurecat divestitures delivered about $670 million of combined pre-tax proceeds and simplified Albemarle into a two-segment lithium-and-bromine business.
  • Global lithium carbonate inventories under three weeks of consumption, cited by CEO Kent Masters, point to a tight near-term supply-demand balance supporting realized pricing.

Bearish Factors 72% confidence

  • The June 9 fire at the Talison Greenbushes joint venture's CGP3 circuit is capping 2026 Energy Storage volume guidance at 225,000-235,000 tonnes, flat to down 4% from 2025, even as pricing improved.
  • Full run-rate at the fire-affected CGP3 circuit isn't expected until the first quarter of 2027, leaving several more quarters of below-capacity output from one of Albemarle's core lithium sources.

Alternative Scenarios 62% confidence

  • If lithium carbonate pricing retraces from its current tight-market levels, Energy Storage segment margins that reached 57% in Q2 could compress even with the lower cost base Albemarle has built.
  • If the Talison Greenbushes CGP3 restart takes longer than the targeted first-quarter-2027 full run-rate, Albemarle's 2026-2027 volume guidance could see a further downward revision.

Who Benefits, Who Loses

PartyStanceReason
Albemarle shareholdersBullishA more than doubled adjusted EBITDA, an EPS beat, raised guidance and a lower capex plan combine to give the stock direct operating leverage to the current tight lithium market.
Downstream lithium buyers on new supply contractsBearishAverage realized lithium carbonate equivalent pricing near $20/kg, up 73% year-over-year, alongside inventories under three weeks of consumption, points to higher near-term procurement costs for battery and cell makers negotiating fresh volumes.

Investor Watchlist 76% confidence

Educational items to monitor — not investment advice.

  • Talison Greenbushes' CGP3 circuit ramp-up toward full run-rate, targeted for the first quarter of 2027.
  • Albemarle's execution against its trimmed roughly $500 million 2026 capex plan.
  • Specialties segment progress toward its raised $1.4-$1.6 billion sales guidance.
  • Global lithium carbonate inventory levels relative to the sub-three-week mark cited in August 2026.

Price Risks 70% confidence

  • A pullback in spot lithium carbonate pricing from current tight-market levels could compress the 57% margin Albemarle's Energy Storage segment posted in Q2 2026.
  • A slower-than-planned ramp-up at the fire-affected Talison Greenbushes CGP3 circuit could pressure 2026-2027 volume guidance further.

Historical Comparison

Q2 2025: Albemarle's Energy Storage segment EBITDA margin was 22%, versus 57% in Q2 2026, as lithium carbonate equivalent pricing recovered from the 2024-2025 oversupply-driven downturn.
2026 capex plan: Albemarle trimmed its 2026 capital expenditure plan to roughly $500 million, reflecting the more disciplined spending approach adopted through the prior downturn, when the company cut costs and idled higher-cost capacity.

Related

Metals lithium

Frequently Asked Questions

Albemarle's Energy Storage (lithium) segment sold 65,000 tonnes of lithium carbonate equivalent at an average realized price near $20 a kilogram, up 73% year-over-year, lifting segment EBITDA 229% to $724 million and pushing overall adjusted EBITDA to $858 million, more than double the prior year.

Albemarle sold a 51% controlling stake in Ketjen, its refining-catalyst business, to KPS Capital Partners, completing the deal March 2, 2026. Combined with an earlier sale of its Eurecat joint-venture stake, the transactions brought in about $670 million of pre-tax proceeds and left Albemarle focused on just two segments: lithium and bromine.

A June 9, 2026 fire at the CGP3 processing circuit curbed lithium spodumene output; the unit restarted August 1 but isn't expected to reach full run-rate until the first quarter of 2027, which is why Albemarle's 2026 Energy Storage volume guidance of 225,000-235,000 tonnes is flat to down 4% from 2025 despite stronger pricing.

Yes. Albemarle raised full-year 2026 guidance to $5.7-$6.0 billion in net sales and $2.4-$2.6 billion in adjusted EBITDA, and also raised Specialties (bromine) segment guidance to $1.4-$1.6 billion in sales and $275-$325 million in EBITDA, while trimming planned capital expenditure to roughly $500 million.

Overall AI confidence for this article: 80%.

Reporting based on information published by Investing.com. Analysis and interpretation by MetalsCost.

← Back to News